ES2151267T3 - Compuestos con actividades anti-inflamatorias e inmunosupresoras. - Google Patents

Compuestos con actividades anti-inflamatorias e inmunosupresoras.

Info

Publication number
ES2151267T3
ES2151267T3 ES97923053T ES97923053T ES2151267T3 ES 2151267 T3 ES2151267 T3 ES 2151267T3 ES 97923053 T ES97923053 T ES 97923053T ES 97923053 T ES97923053 T ES 97923053T ES 2151267 T3 ES2151267 T3 ES 2151267T3
Authority
ES
Spain
Prior art keywords
inflammatory
alkyl
compounds
immunosuppressive activities
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97923053T
Other languages
English (en)
Inventor
Giorgio Bertolini
Mauro Biffi
Flavio Leoni
Jacques Mizrahi
Gianfranco Pavich
Paolo Mascagni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Italfarmaco SpA
Original Assignee
Italfarmaco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11374259&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2151267(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Italfarmaco SpA filed Critical Italfarmaco SpA
Application granted granted Critical
Publication of ES2151267T3 publication Critical patent/ES2151267T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
    • C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

SE EXPONEN COMPUESTOS DE FORMULA (I), EN LA QUE R'' ES HIDROGENO O ALQUILO; A ES ADAMANTILO O UN RESIDUO MONO-, BI- O TRICICLICO OPTATIVAMENTE INSATURADO, UN RESIDUO HETEROCICLICO Y/O SUSTITUIDO POR HIDROXI, ALCANOILOXI, AMINO, AMINOALQUILO, HALOGENO, ALQUILO, TRIALQUILAMONIOALQUILO; (A) EN UNA CADENA DE 1 A 5 ATOMOS DE CARBONO QUE CONTIENE OPTATIVAMENTE UN DOBLE ENLACE O UN NR''; R ES HIDROGENO O FENILO; X ES O O NR'' O ESTA AUSENTE; R Y M SON INDEPENDIENTEMENTE, 0, 1 O 2; B ES FENILENO O CICLOHEXILENO; Y ES HIDROXI O AMINOALQUILO OPTATIVAMENTE INTERRUMPIDO POR UN O; POSEEN ACTIVIDADES ANTI - INFLAMATORIAS E INMUNOSUPRESORAS.
ES97923053T 1996-05-14 1997-05-12 Compuestos con actividades anti-inflamatorias e inmunosupresoras. Expired - Lifetime ES2151267T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000968A IT1283637B1 (it) 1996-05-14 1996-05-14 Composti ad attivita' antinfiammatoria ed immunosoppressiva

Publications (1)

Publication Number Publication Date
ES2151267T3 true ES2151267T3 (es) 2000-12-16

Family

ID=11374259

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97923053T Expired - Lifetime ES2151267T3 (es) 1996-05-14 1997-05-12 Compuestos con actividades anti-inflamatorias e inmunosupresoras.

Country Status (19)

Country Link
US (1) US6034096A (es)
EP (1) EP0901465B1 (es)
JP (1) JP4108127B2 (es)
CN (1) CN1105100C (es)
AU (1) AU713300B2 (es)
BR (1) BR9709234B8 (es)
CA (1) CA2254066C (es)
CZ (1) CZ293233B6 (es)
DE (1) DE69703207T2 (es)
DK (1) DK0901465T3 (es)
ES (1) ES2151267T3 (es)
GR (1) GR3035128T3 (es)
HU (2) HUP9902818A3 (es)
IT (1) IT1283637B1 (es)
PL (1) PL187527B1 (es)
PT (1) PT901465E (es)
RU (1) RU2177473C2 (es)
SK (1) SK282174B6 (es)
WO (1) WO1997043251A1 (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU772575B2 (en) 1998-12-10 2004-04-29 F. Hoffmann-La Roche Ag Procollagen C-proteinase inhibitors
JP4565747B2 (ja) * 1999-02-04 2010-10-20 エスケー ホルディングス カンパニー リミテッド テトラヒドロイソキノリンアルカノール誘導体及びそれを含む薬学的組成物
EP1165531A1 (en) * 1999-03-19 2002-01-02 Du Pont Pharmaceuticals Company N-adamant-1-yl-n'- 4-chlorobenzothiazol-2-yl] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent
ES2293993T3 (es) * 2000-05-31 2008-04-01 Santen Pharmaceutical Co., Ltd. Inhibidores de produccion de tnf-alfa.
ATE310719T1 (de) * 2000-09-29 2005-12-15 Topotarget Uk Ltd Carbaminsäurederivate enthaltend eine amidgruppe als hdac-inhibitoren
ITMI20011733A1 (it) * 2001-08-07 2003-02-07 Italfarmaco Spa Derivati dell'acido idrossamico inibitori degli enzimi istone deacetilasi, quali nuovi farmaci antiinfiammatori inibenti la sintesi di citoc
PE20030701A1 (es) * 2001-12-20 2003-08-21 Schering Corp Compuestos para el tratamiento de trastornos inflamatorios
JPWO2003070691A1 (ja) * 2002-02-21 2005-06-09 財団法人大阪産業振興機構 Ｎ−ヒドロキシカルボキサミド誘導体
ITMI20030025A1 (it) * 2003-01-10 2004-07-11 Italfarmaco Spa Derivati dell'acido idrossammico ad attivita' antinfiammatoria.
ITMI20030063A1 (it) * 2003-01-17 2004-07-18 Italfarmaco Spa Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico.
ITMI20030064A1 (it) 2003-01-17 2004-07-18 Italfarmaco Spa Uso dei derivati dell'acido idrossamico per la preparazione
US7291744B2 (en) 2003-11-13 2007-11-06 Bristol-Myers Squibb Company N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
DK1696898T3 (en) * 2003-12-02 2016-02-22 Univ Ohio State Res Found ZN2 + -CHELATING DESIGN-BASED SHORT-CHAIN FAT ACIDS AS AN UNKNOWN CLASS OF HISTONDEACETYLASE INHIBITORS
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
ITMI20041347A1 (it) * 2004-07-05 2004-10-05 Italfarmaco Spa Derivati di alfa-amminoacidi ad attivita'antiinfiammatoria
US20100152188A1 (en) * 2005-08-05 2010-06-17 Akella Satya Surya Visweswara Srinivas Novel Heterocyclic Compounds
IT1392908B1 (it) 2008-09-29 2012-04-02 Italfarmaco Spa Uso degli inibitori delle istone-deacetilasi per la cura di sindromi mieloproliferative philadelphia-negative
CA2740559C (en) * 2008-10-15 2016-02-16 Generics [Uk] Limited Improved process
US8754129B2 (en) 2008-11-26 2014-06-17 Generics [Uk] Limited Crystalline vorinostat form VI
KR101168801B1 (ko) 2009-03-27 2012-07-25 주식회사종근당 신규한 하이드록사메이트 유도체, 이의 제조방법, 및 이를 함유하는 약제학적 조성물
IT1396915B1 (it) 2009-10-23 2012-12-20 Italfarmaco Spa Dietil-[6-(4-idrossicarbamoil-fenil-carbamoilossimetil)-naftalen-2-il-metil]-ammonio cloruro ed altri derivati della n-idrossi-benzammide per l'uso nel trattamento di infezioni da hiv.
IT1397912B1 (it) 2010-01-28 2013-02-04 Chemi Spa Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato.
US8217079B2 (en) * 2010-03-26 2012-07-10 Italfarmaco Spa Method for treating Philadelphia-negative myeloproliferative syndromes
EP2683371B1 (en) 2011-03-09 2020-10-21 Cereno Scientific AB Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
AU2012368818B2 (en) 2012-02-03 2017-11-16 Italfarmaco S.P.A. Diethyl- [6- (4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl) - naphthalen-2-yl-methyl] -ammonium chloride for use in the treatment of muscular dystrophy
ITUB20155193A1 (it) 2015-11-03 2017-05-03 Italfarmaco Spa Sospensioni orali di Givinostat fisicamente e chimicamente stabili
WO2018054960A1 (en) 2016-09-21 2018-03-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for predicting and treating resistance to chemotherapy in npm-alk(+) alcl
IT201900003281A1 (it) 2019-03-06 2020-09-06 Chemi Spa Processo per preparare {6-[(dietilammino)metil]naftalen-2-il}metil [4-(idrossicarbamoil)fenil]carbammato ad elevata purezza

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800498A (en) * 1954-09-12 1957-07-23 Lab Dausse Carbamates of dialkylaminoalkyl p-aminobenzoates
DK143104C (da) * 1970-09-09 1981-11-09 Ciba Geigy Ag Analogifremgangsmaade til fremstilling af anilinophenylacetamidderivater eller salte deraf
US3728380A (en) * 1971-05-17 1973-04-17 Morton Norwich Products Inc P-chlorobenzamidoacetohydroxamic acid
US3804888A (en) * 1971-05-17 1974-04-16 Morton Norwich Products Inc 2-p-nitrobenzamidoacetohydroxamic acid
FR2354315A1 (fr) * 1976-06-10 1978-01-06 Eisai Co Ltd Nouveaux derives d'acide hydroxamique et medicaments en contenant
IL60888A (en) * 1978-06-16 1984-07-31 Yeda Res & Dev Substrates and process for the quantitative assay of enzymes
JPS5668650A (en) * 1979-11-07 1981-06-09 Otsuka Pharmaceut Co Ltd Benzoic acid amide derivative
GB8506870D0 (en) * 1985-03-16 1985-04-17 Wellcome Found Aryl derivatives
US4792560A (en) * 1985-04-03 1988-12-20 Rorer Pharmaceutical Corporation Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways
US4711900A (en) * 1986-07-23 1987-12-08 E. R. Squibb & Sons, Inc. Certain arylalkyl or pyridylalkyl hydroxamates useful for treating allergies and asthma
US4681894A (en) * 1986-09-26 1987-07-21 Ortho Pharmaceutical Corporation Hydroxamic acids and esters
US5280015A (en) * 1990-09-05 1994-01-18 The United States Of America As Represented By The Department Of Health And Human Services 2-substituted adenosines and 2-substituted adenosine 5'-carboxamides

Also Published As

Publication number Publication date
ITMI960968A0 (es) 1996-05-14
DE69703207T2 (de) 2001-02-01
AU713300B2 (en) 1999-11-25
SK157998A3 (en) 1999-04-13
WO1997043251A1 (en) 1997-11-20
EP0901465A1 (en) 1999-03-17
CZ293233B6 (cs) 2004-03-17
PL329873A1 (en) 1999-04-12
BR9709234B8 (pt) 2014-04-15
IT1283637B1 (it) 1998-04-23
JP2000510472A (ja) 2000-08-15
JP4108127B2 (ja) 2008-06-25
AU2896497A (en) 1997-12-05
PL187527B1 (pl) 2004-07-30
GR3035128T3 (en) 2001-04-30
PT901465E (pt) 2001-01-31
DK0901465T3 (da) 2000-12-18
DE69703207D1 (de) 2000-11-02
ITMI960968A1 (it) 1997-11-14
CZ366798A3 (cs) 1999-06-16
RU2177473C2 (ru) 2001-12-27
HUP9902818A3 (en) 2001-10-29
HU225650B1 (en) 2007-05-29
CA2254066A1 (en) 1997-11-20
CN1221403A (zh) 1999-06-30
BR9709234B1 (pt) 2009-01-13
US6034096A (en) 2000-03-07
BR9709234A (pt) 1999-08-10
CN1105100C (zh) 2003-04-09
CA2254066C (en) 2007-09-11
SK282174B6 (sk) 2001-11-06
EP0901465B1 (en) 2000-09-27

Similar Documents

Publication Publication Date Title
ES2151267T3 (es) Compuestos con actividades anti-inflamatorias e inmunosupresoras.
AR006390A1 (es) Derivados de lactama
ES2196502T3 (es) Composicion y metodo para inhibir el desarrollo de microorganismos que incluye hipobromito sodico estabilizado e isotiazolonas.
GT199600026A (es) Isotiazolonas
ES2116289T3 (es) N,n'-dihaloimidazolidin-4-onas.
CO4770945A1 (es) Composiciones orales antiplaca que contienen fenol alquila- tado antibacterial
DE69133299D1 (de) Aminosulfonylcarbamate
NO930133D0 (no) Fremgangsmaater for aa redusere mengden av sulfider i kloakkgass
BR9813781A (pt) Removedor de tinta de baixa toxicidade
ES2057834T3 (es) Compuestos de triazol de utilidad como desactivadores de metales.
DK1063886T3 (da) Desinficerende middel
EA200200810A1 (ru) Конденсированные соединения азола и их применение в качестве гипогликаемических агентов
ES2189285T3 (es) Nuevas piranonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
DK0842165T3 (da) Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler
ES2059931T3 (es) Procedimiento para el tratamiento de la hipertrofia e hiperplasia cardiaca asi como vascular.
ES2193141T3 (es) Poliglicidileteres y su utilizacion.
ES2159921T3 (es) Imidazolinas sustituidas por un nucleo heterociclico, como 2-alfa-antagonistas.
FI914526A0 (fi) Foerening, dess framstaellning och anvaendning.
ES2193489T3 (es) Procedimiento de isomerizacion de los compuestos aromaticos de ocho atomos de carbono que incluye un reciclado.
NO960190L (no) Mineralfiberblanding
ES2053279T3 (es) Composiciones lubricantes que contienen derivados de benzotriazol.
CO4560332A1 (es) Benciloxi aromaticos sustituidos y su uso como fungicidas e insecticidas
BR9815448A (pt) Derivados de imino-aza-antraciclinona para o tratamento de amiloidose
AR004551A1 (es) Compuestos fungicidas (b)
ES2069132T3 (es) Composiciones herbicidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 901465

Country of ref document: ES